|Description||A 1120 is a retinol-binding protein 4 (RBP4) antagonist (Ki = 8.3 nM) that can reduce serum RBP4 and retinol, and displaces transthyretin (TTR) from RBP4-TTR complexes.|
|Brife Description||RBP4 antagonist|
|Purity||≥99% by HPLC|
|Synonyms||A-1120; 2-(4-(2-(Trifluoromethyl)phenyl)piperidine-1-carboxamido)benzoic acid|
NKH477 is a water-soluble analog of forskolin, which is an adenylyl cyclase activator, but it is sparingly soluble in aqueous solutions. It has both inotropic a...
Intiquinatine may have potential anticancer activity.
Dexpemedolac is a bio-active chemical compound,but no detailed information is published.
GSK-1440115 is an orally active urotensin II receptor antagonist. It is used for the treatment of asthma.
Quin C1, a quinazolinone derivative, is a potent and selective FPR2 agonist (EC50 = 40 nM). It was identified as a biased agonist, as it stimulated calcium mobi...
Omeprazole sulphone is the major metabolite of omeprazole, which is the gastric proton pump inhibitor. It is produced by cytochrome P450 (CYP)3A4 sulfoxidation ...
Exherin, also known as ADH-1, is a small, cyclic pentapeptide vascular-targeting agent with potential antineoplastic and antiangiogenic activities. ADH-1 select...
MDL-72274 is a selective SSAO inhibitor. It is a potent (IC50 = 10(-9) M) inhibitor of both MAO-B and SSAO, with 190-fold lower affinity for MAO-A. MDL-72974 ca...